萬里馬(300591.SZ):控股股東及其一致行動人合計持股比例減少1.66%至50.16%
格隆匯 11 月 11日丨萬里馬(300591.SZ)公佈,公司於近日接到林大耀的通知,林大耀於2020年11月10日通過集中競價交易方式減持公司股份9.09萬股,佔減持當日公司總股本的0.03%。自前次披露簡式權益變動報告書以來,因公司可轉債轉股被動稀釋及林大耀的主動減持,公司控股股東及其一致行動人林大耀、林大洲、林大權、林彩虹合計持股比例由51.82%變動至50.16%,股份比例減少1.66%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.